TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07389278: Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)

Sponsor: Sabine Mueller, MD, PhD · Phase: PHASE1/PHASE2 · Area: ONCOLOGY · Target Enrollment: 97 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$12,566,400

Rescue Site Savings

+$8,285,970

Unlock Full NCT07389278 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07389278 Rescue Dossier →